全文获取类型
收费全文 | 19004篇 |
免费 | 1404篇 |
国内免费 | 98篇 |
专业分类
耳鼻咽喉 | 160篇 |
儿科学 | 471篇 |
妇产科学 | 241篇 |
基础医学 | 2548篇 |
口腔科学 | 524篇 |
临床医学 | 1958篇 |
内科学 | 3872篇 |
皮肤病学 | 283篇 |
神经病学 | 1693篇 |
特种医学 | 1510篇 |
外科学 | 2775篇 |
综合类 | 226篇 |
一般理论 | 16篇 |
预防医学 | 1204篇 |
眼科学 | 505篇 |
药学 | 1099篇 |
中国医学 | 21篇 |
肿瘤学 | 1400篇 |
出版年
2023年 | 130篇 |
2022年 | 245篇 |
2021年 | 515篇 |
2020年 | 312篇 |
2019年 | 410篇 |
2018年 | 475篇 |
2017年 | 356篇 |
2016年 | 411篇 |
2015年 | 529篇 |
2014年 | 699篇 |
2013年 | 859篇 |
2012年 | 1340篇 |
2011年 | 1354篇 |
2010年 | 844篇 |
2009年 | 802篇 |
2008年 | 1154篇 |
2007年 | 1205篇 |
2006年 | 1046篇 |
2005年 | 972篇 |
2004年 | 911篇 |
2003年 | 803篇 |
2002年 | 664篇 |
2001年 | 295篇 |
2000年 | 288篇 |
1999年 | 249篇 |
1998年 | 278篇 |
1997年 | 229篇 |
1996年 | 211篇 |
1995年 | 161篇 |
1994年 | 135篇 |
1993年 | 144篇 |
1992年 | 136篇 |
1991年 | 138篇 |
1990年 | 121篇 |
1989年 | 147篇 |
1988年 | 133篇 |
1987年 | 144篇 |
1986年 | 114篇 |
1985年 | 128篇 |
1984年 | 117篇 |
1983年 | 91篇 |
1982年 | 97篇 |
1981年 | 68篇 |
1980年 | 83篇 |
1979年 | 104篇 |
1978年 | 76篇 |
1977年 | 77篇 |
1976年 | 72篇 |
1975年 | 64篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
82.
83.
Reiss J Bonin M Schwegler H Sass JO Garattini E Wagner S Lee HJ Engel W Riess O Schwarz G 《Molecular genetics and metabolism》2005,85(1):12-20
Molybdenum cofactor (Moco)-deficiency is a lethal autosomal recessive disease, for which until now no effective therapy is available. The biochemical hallmark of this disorder is the inactivity of the Moco-dependent sulfite oxidase, which results in elevated sulfite and diminished sulfate levels throughout the organism. In humans, Moco-deficiency results in neurological damage, which is apparent in untreatable seizures and various brain dysmorphisms. We have recently described a murine model for Moco-deficiency, which reflects all enzyme and metabolite changes observed in the patients, and an efficient therapy using a biosynthetic precursor of Moco has been established in this animal model. We now analyzed these mice in detail and excluded morphological brain damage, while expression analysis with microarrays indicates a massive cell death program. This neuronal damage appears to be triggered by elevated sulfite levels and is ameliorated in affected embryos by maternal clearance. 相似文献
84.
85.
86.
Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity 总被引:2,自引:0,他引:2
Nicole C. Johnson Miriam E. Dillard Peter Baluk Donald M. McDonald Natasha L. Harvey Sharon L. Frase Guillermo Oliver 《Genes & development》2008,22(23):3282-3291
The activity of the homeobox gene Prox1 is necessary and sufficient for venous blood endothelial cells (BECs) to acquire a lymphatic endothelial cell (LEC) fate. We determined that the differentiated LEC phenotype is a plastic, reprogrammable condition that depends on constant Prox1 activity for its maintenance. We show that conditional down-regulation of Prox1 during embryonic, postnatal, or adult stages is sufficient to reprogram LECs into BECs. Consequently, the identity of the mutant lymphatic vessels is also partially reprogrammed as they acquire some features typical of the blood vasculature. siRNA-mediated down-regulation of Prox1 in LECs in culture demonstrates that reprogramming of LECs into BECs is a Prox1-dependent, cell-autonomous process. We propose that Prox1 acts as a binary switch that suppresses BEC identity and promotes and maintains LEC identity; switching off Prox1 activity is sufficient to initiate a reprogramming cascade leading to the dedifferentiation of LECs into BECs. Therefore, LECs are one of the few differentiated cell types that require constant expression of a certain gene to maintain their phenotypic identity. 相似文献
87.
C1-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro 总被引:1,自引:0,他引:1
We have previously shown that activated C1s complement and activated T
cells cleave beta2-microglobulin (beta2m) in vitro leading to the formation
of desLys58 beta2m. This process can specifically be inhibited by
C1-esterase inhibitor (C1-inh). Furthermore we showed that exogenously
added desLys58 beta2m in nanomolar amounts to a one-way allogenic mixed
lymphocyte culture (MLC) increased the endogenous production of IL-2 and
the generation of allo-specific cytotoxic T lymphocytes. C1-inh was
purified from fresh human plasma and added to human or murine MLC and
mitogen-stimulated lymphocyte cultures grown in the presence of
complement-inactivated serum. Read-outs were cell proliferation, lymphokine
production and development of T cell-mediated cytotoxicity. We found that
addition of C1-inh to MLC and mitogen- exposed murine and human lymphocyte
cultures inhibited proliferation, the development of allospecific cytotoxic
activity, and changed the endogenous production of IL-2, IL-4, IL-10, IL-12
and IFN-gamma. These data clearly demonstrate a regulatory function of
C1-inh on T cell- mediated immune functions.
相似文献
88.
Niedhart C Maus U Piroth W Miltner O Schmidt-Rohlfing B Siebert CH 《Journal of biomedical materials research. Part B, Applied biomaterials》2004,71(1):123-129
The gold standard for bone substitution is the autologous bone graft, but because of its limited supply and the associated morbidity, the search for synthetic alternatives is necessary. A new in situ setting tricalcium phosphate cement was implanted in a trepanation defect (9.4 mm diameter, 10 mm depth) in the distal femoral epiphysis of sheep. Empty cavities and autologous bone graft were used as controls. Histologic and histomorphometric examinations were carried out after 12 weeks. Nearly 90% of the implanted cement was resorbed and replaced by ingrown bone with close contact between surrounding bone, new bone, and remaining cement particles. The amount of bone in the defect area was significantly higher in defects filled with cement relative to defects filled with autologous bone graft (mean 27 vs. 21%, 95% confidence intervals 23 to 31 and 18 to 23, p = 0.026). In conclusion, this new in situ setting cement is bioactive, resorbable, and osteoconductive. It will be useful as an alternative to autologous bone graft to fill stable defects. 相似文献
89.
Ehling D Kennerknecht I Junge A Prager B Exeler R Behre B Horst J Schmitt-John T Bartsch O Wirth J 《American journal of medical genetics. Part A》2004,131(3):265-272
We describe two unrelated patients with cytogenetically visible deletions of 21q22.2-q22.3 and mild phenotypes. Both patients presented minor dysmorphic features including thin marfanoid build, facial asymmetry, downward-slanting palpebral fissures, depressed nasal bridge, small nose with bulbous tip, and mild mental retardation (MR). FISH and molecular studies indicated common deleted areas but different breakpoints. In patient 1, the breakpoint was fine mapped to a 5.2 kb interval between exon 5 and exon 8 of the ETS2 gene. The subtelomeric FISH probe was absent on one homologue 21 indicating a terminal deletion spanning approximately 7.9 Mb in size. In patient 2, the proximal breakpoint was determined to be 300-700 kb distal to ETS2, and the distal breakpoint 2.5-0.3 Mb from the 21q telomere, indicating an interstitial deletion sized approximately 4.7-7.3 Mb. The 21q- syndrome is rare and typically associated with a severe phenotype, but different outcomes depending on the size and location of the deleted area have been reported. Our data show that monosomy 21q of the area distal to the ETS2 gene, representing the terminal 7.9 Mb of 21q, may result in mild phenotypes comprising facial anomalies, thin marfanoid build, and mild MR, with or without signs of holoprosencephaly. 相似文献
90.
Can Ding Rolf Beetz Gabriele Rittner Oliver Bartsch 《American journal of medical genetics. Part A》2020,182(5):1032-1040
There are two forms of diabetes insipidus, central (neurohypophyseal), and nephrogenic, caused by pathogenic variants in the AVP gene and the AVPR2 or AQP2 genes, respectively. We report on a four‐generation family, seven individuals had central diabetes insipidus (CDI) and the female index patient seen from age 16 to 26 years had (mild) nephrogenic diabetes insipidus. In her father with CDI, a known pathogenic heterozygous AVP variant c.232_234del p.(Glu78del) was identified, confirming the diagnosis of CDI in him and the other affected family members. In the proband, molecular analysis disclosed a novel heterozygous AVPR2 gene variant, c.962A > T p.(Asn321Ile) and an extremely skewed X‐inactivation, confirming X‐linked nephrogenic diabetes insipidus (XL‐NDI). Whole exome sequencing showed no further causative mutation. This is the first report on the co‐existence of CDI and NDI in one family. Our review of symptomatic female AVPR2 heterozygotes includes 23 families with at least one affected female (including this study). There were 21 different causative mutations. Mutation types in females did not differ from those in males. Both severe XL‐NDI and mild forms were reported in females. All six females with severe XL‐NDI had complete loss‐of‐function (null) mutations. The remaining 17 female probands had milder XL‐NDI caused by 14 missense variants and three null variants of the AVPR2 gene. X‐inactivation was studied in nine of these females; all showed extreme or slight skewing. The review underlines that XL‐NDI in female AVPR2 heterozygotes is always accompanied by skewed X‐inactivation, emphasizing a need for X‐inactivation studies in these females. 相似文献